Founders Fund V Management

Latest statistics and disclosures from Founders Fund V Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are CYTH, UBX, RGTI, and represent 100.00% of Founders Fund V Management's stock portfolio.
  • Added to shares of these 1 stock: CYTH (+$764M).
  • Started 1 new stock position in CYTH.
  • Reduced shares in these 1 stock: Applied Molecular Trans.
  • Sold out of its position in Applied Molecular Trans.
  • Founders Fund V Management was a net buyer of stock by $764M.
  • Founders Fund V Management has $947M in assets under management (AUM), dropping by 117787.23%.
  • Central Index Key (CIK): 0001697733

Tip: Access up to 7 years of quarterly data

Positions held by Founders Fund V Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Founders Fund V Management

Founders Fund V Management holds 3 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cyclo Therapeutics Com New (CYTH) 80.8 $764M NEW 481k 1590.00
 View chart
Unity Biotechnology Com New (UBX) 10.0 $95M 49k 1930.00
 View chart
Rigetti Computing Common Stock (RGTI) 9.2 $87M 89k 985.00
 View chart

Past Filings by Founders Fund V Management

SEC 13F filings are viewable for Founders Fund V Management going back to 2020